Endocrine-Related Cancer or reduced-price access for institutions in certain developing countries to health-related research. The archive of published content from 1994 to 1997 is available to purchase by institutions as part of the Society for Endocrinology Archive. "Endocrine-Related Cancer" is abstracted and indexed in: Endocrine-Related Cancer Endocrine-Related Cancer is a monthly peer-reviewed medical journal covering cancers in endocrine organs — such as the breast, prostate, pituitary, testes, ovaries, and neuroendocrine system — and hormone-dependent cancers occurring elsewhere in the body. Its scope covers basic, translational, clinical and experimental studies. The journal is published by Bioscientifica on behalf of the Society for Endocrinology.
Endocrine disruptor are appropriate", however this study was conducted over a year before the EPA announced the final structure of the screening program. The EPA is still finding it difficult to execute a credible and efficient endocrine testing program. As of 2016, the EPA had estrogen screening results for 1,800 chemicals. In 2013, a number of pesticides containing endocrine disrupting chemicals were in draft EU criteria to be banned. On the 2nd May, US TTIP negotiators insisted the EU drop the criteria. They stated that a risk-based approach should be taken on regulation. Later the same day Catherine Day wrote to Karl